Lung Cancer Diagnostic and Screening Market Poised for Growth, Expected to Reach $3.3 Billion by 2028
Lung Cancer Diagnostic and Screening Global Market Report 2024: Market Size, Trends, And Global Forecast 2024-2033
The Business Research Company’s Lung Cancer Diagnostic and Screening Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033
LONDON, GREATER LONDON, UK, July 5, 2024 /EINPresswire.com/ -- The lung cancer diagnostic and screening market is witnessing rapid growth, projected to increase from $2.11 billion in 2023 to $2.32 billion in 2024, at a compound annual growth rate (CAGR) of 10.2%. This growth is attributed to advancements in digital imaging, the standardization of screening protocols, and public health initiatives against tobacco use.
Rising Incidence of Lung Cancer Drives Market Growth
The increasing prevalence of lung cancer, coupled with a growing emphasis on early detection and the expansion of high-risk screening programs, is expected to propel the market to $3.3 billion by 2028, with a CAGR of 9.2%. Government initiatives and funding, alongside a shift towards personalized medicine, further contribute to this growth.
Explore the global lung cancer diagnostic and screening market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=12043&type=smp
Major Players and Market Trends
Key players such as Pfizer Inc., F. Hoffmann-La Roche AG, and Bristol-Myers Squibb Company are focusing on developing blood-based tests and integrating artificial intelligence (AI) to enhance screening accuracy. For instance, Thermo Fisher Scientific Inc. and AstraZeneca PLC are pioneering advancements in biomarker testing, while Abbott Laboratories Inc. and Medtronic Plc. are advancing imaging technologies for early-stage detection.
Innovative trends include the emergence of novel screening modalities and the rise in liquid biopsy adoption, aiming to improve diagnostic precision and patient outcomes.
Market Segments
• Product: Instruments, Consumables And Accessories
• Test: Biomarkers Tests, Imaging Test, Biopsy, Blood Test, Other Tests
• Cancer Type: Non-Small Cell Lung Cancer, Small Cell Lung Cancer
• End User: Hospital, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Other End-Users
Geographical Insights: North America Leads the Market
North America dominated the lung cancer diagnostic and screening market in 2023 and is anticipated to continue leading due to robust healthcare infrastructure and high adoption of advanced diagnostic technologies.
Make your report purchase here and explore the whole industry's data as well
https://www.thebusinessresearchcompany.com/report/lung-cancer-diagnostic-and-screening-global-market-report
Lung Cancer Diagnostic And Screening Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Trends, opportunities, strategies and so much more.
The Lung Cancer Diagnostic And Screening Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on lung cancer diagnostic and screening market size, lung cancer diagnostic and screening market drivers and trends, lung cancer diagnostic and screening market major players, competitors' revenues, market positioning, and market growth across geographies. The lung cancer diagnostic and screening market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Point-Of-Care Diagnostics Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report
Veterinary Diagnostic Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-diagnostic-equipment-global-market-report
Transplant Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report
About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn
Pioneering the Future of Cancer Care: Generic Oncology Drugs Market Insights
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
